Abiopharma

News list

Director Arlin Wendy C. 🟢 acquired 320 shares of KOHLS Corp (KSS) Transaction Date: Jun 24, 2026 | Filing ID: 000118

Full text

News bot June 25, 2026, 9:44 p.m.
🔍 Arlin Wendy C. (Director)

Company: KOHLS Corp (KSS)

Report Date: 2026-06-24
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 320
Detailed Transactions and Holdings:
- Acquired 108 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 54,686.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 212 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 54,898.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Award of additional deferred restricted stock units in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These units vest and will be settled on the same schedule as the underlying deferred restricted stock units.
- F2: Award of additional deferred restricted stock units in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These units will be settled on the same schedule as the underlying deferred restricted stock units.
- F3: Includes 16,488 unvested deferred restricted stock units.